GERN stock news
US Markets

Geron Corporation (NASDAQ: GERN) Stock Spikes as FDA Greenlights Rare Blood Cancer Therapy

/

Geron Corporation (NASDAQ: GERN) stock surged during intraday trading Friday after the biopharma company received FDA approval for RYTELO, a […]

Geron Corporation (NASDAQ: GERN) Stock Spikes as FDA Greenlights Rare Blood Cancer Therapy Read More »